Chinese medical device maker Lepu enters India

Sets up subsidiary, to explore local manufacturing avenues

May 10, 2018 09:21 pm | Updated May 11, 2018 03:10 pm IST - HYDERABAD

Chinese medical device maker Lepu Medical Technology (Beijing) Co. has entered the Indian market through a subsidiary and is keen to explore opportunities for local manufacturing as well as collaborations.

Fifth global subsidiary

Vice president Aaron Lin said Lepucare (India) Vascular Solutions Pvt. Ltd., the subsidiary, is the fifth such set up by the firm globally, with the U.S., the Netherlands, France and Turkey home to the other units.

The Chinese firm, whose turnover last year was a little more than $700 million, is engaged in development, manufacturing and distribution of high-tech medical devices, equipment, mobile medical service and pharmaceuticals.

The company plans to kick-start the India operations later this month and accordingly has recruited experienced professionals, Mr. Lin said here on Thursday.

Lepu’s product portfolio comprises coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices and pacemakers. The whole range of PCI (percutaneous coronary intervention) products are to be introduced initially in the country.

A release from the company said India had grown into one of the prime markets for medical devices and equipment andLepu saw demand in India outpacing that of the leading markets in America and Europe.

Besides exploring local manufacturing, Lepu wants to form collaborations for tapping opportunities in the areas of telemedicine and mobile medical services, Mr. Lin said, replying to queries.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.